LISA DEAFENBAUGH: Open Payments
NPI 1326157249 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 9 payments from 6 companies in 2025. Trend: 2023 $2,276 · 2024 $703 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $116 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| GENZYME CORPORATION | 1 | $30 |
| Grifols USA, LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Rhapsido, DUPIXENT, Prolastin-C Liquid, AIRSUPRA, NUCALA.
Industry payments across VA — which companies pay providers there.
